POST SORAFENIB SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR PROGRESSION AND LIVER IMPAIRMENT

被引：0
|
作者：
Iavarone, M. [1 ]
Cabibbo, G. [2 ]
Biolato, M. [3 ]
Della Corte, C. [1 ]
Maida, M. [2 ]
Basso, M. [3 ]
Vavassori, S. [1 ]
Camma, C. [2 ]
Grieco, A. [3 ]
Craxi, A. [2 ]
Colombo, M. [1 ]
机构：
[1] Univ Milan, AM &A Migliavacca Ctr Liver Dis, Fdn IRCCS Ca Granda Maggiore Hosp, Div Gastroenterol 1, Milan, Italy
[2] Univ Palermo, Gastroenterol Sect, DIBIMIS, Policlin P Giaccone, Palermo, Italy
[3] UCSC Catholic Univ Rome, Dept Internal Med, Gemelli Hosp, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
10.1016/j.dld.2014.01.082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-42
引用
收藏
页码：E35 / E36
页数：2
相关论文
共 50 条
  • [1] POST SORAFENIB SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR PROGRESSION AND LIVER IMPAIRMENT
    Iavarone, M.
    Cabibbo, G.
    Biolato, M.
    Della Corte, C.
    Maida, M.
    Basso, M.
    Vavassori, S.
    Camma, C.
    Grieco, A.
    Craxi, A.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S51 - S51
  • [2] Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
    Sadahisa Ogasawara
    Tetsuhiro Chiba
    Yoshihiko Ooka
    Eiichiro Suzuki
    Naoya Kanogawa
    Tomoko Saito
    Tenyu Motoyama
    Akinobu Tawada
    Fumihiko Kanai
    Osamu Yokosuka
    Investigational New Drugs, 2016, 34 : 255 - 260
  • [3] Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Suzuki, Eiichiro
    Kanogawa, Naoya
    Saito, Tomoko
    Motoyama, Tenyu
    Tawada, Akinobu
    Kanai, Fumihiko
    Yokosuka, Osamu
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 255 - 260
  • [4] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [5] The impact of post-progression survival on overall survival of patients with advanced hepatocellular carcinoma treated by sorafenib therapy
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Arai, Kuniaki
    Kagaya, Takashi
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY, 2013, 58 : 1221A - 1221A
  • [6] Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression
    Apostolidis, Leonidas
    Pfeiffenberger, Jan
    Gotthardt, Daniel
    Radeleff, Boris
    Mehrabi, Arianeb
    Schemmer, Peter
    Jaeger, Dirk
    Schirmacher, Peter
    Stremmel, Wolfgang
    Schulze-Bergkamen, Henning
    Springfeld, Christoph
    Weiss, Karl Heinz
    GASTROINTESTINAL TUMORS, 2018, 5 (1-2) : 38 - 46
  • [7] Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis
    Schuette, Kerstin
    Zimmermann, Lars
    Bornschein, Jan
    Csepregi, Antal
    Ruehl, Ricarda
    Ricke, Jens
    Malfertheiner, Peter
    DIGESTION, 2011, 83 (04) : 275 - 282
  • [8] Doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2011, 8 (2) : 61 - 61
  • [9] Alpha-fetoprotein predicts survival and tumor progression in patients with hepatocellular carcinoma treated with sorafenib
    Pinter, Matthias
    Sieghart, Wolfgang
    Graziadei, Ivo
    Vogel, Andreas
    Maieron, Andreas
    Koenigsberg, Robert
    Kornek, Gabriela
    Peck-Radosavljevic, Markus
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A24 - A24
  • [10] The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
    Caputo, Francesco
    Dadduzio, Vincenzo
    Tovoli, Francesco
    Bertolini, Giulia
    Cabibbo, Giuseppe
    Cerma, Krisida
    Vivaldi, Caterina
    Faloppi, Luca
    Rizzato, Mario Domenico
    Piscaglia, Fabio
    Celsa, Ciro
    Fornaro, Lorenzo
    Marisi, Giorgia
    Conti, Fabio
    Silvestris, Nicola
    Silletta, Marianna
    Lonardi, Sara
    Granito, Alessandro
    Stornello, Caterina
    Massa, Valentina
    Astara, Giorgio
    Delcuratolo, Sabina
    Cascinu, Stefano
    Scartozzi, Mario
    Casadei-Gardini, Andrea
    PLOS ONE, 2020, 15 (05):
12345